[一个病理完整反应的案例,通过手术前布利祖马布治疗横向结肠癌而实现]
Yo Akazawa1, Hajime Hirose, Shu Okamura
1Dept. of Surgery, Suita Municipal Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|February 2, 2024
概括
本案例研究突出了成功的新辅助化疗 (NAC) 方法,用于横向结肠癌与十二指肠侵袭. 布罗利祖马布治疗导致完全临床响应 (cCR) 和病理完全响应 (pCR),使治疗手术成为可能.
科学领域:
- 胃肠道学和瘤学
- 在结肠直肠癌中使用新辅助化疗 (NAC).
- 在胃肠道恶性病的免疫疗法.
背景情况:
- 一个77岁的女性,有多种癌症病变的病史,呈现出贫血.
- 对横横结肠癌的诊断与怀疑的十二指肠侵袭对前期R0切除提出了挑战.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...